Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 971 results for "glaxo"

GlaxoSmithKline (GSK) Stock Rises Today on Positive Experiment...

By Andrew Meola | 12/18/14 - 03:11 PM EST NEW YORK ( TheStreet ) -- Shares of GlaxoSmithKline ( GSK ) rose 2.94% to $43.28 in afternoon trading Thursday after the pharmaceutical company announced its experimental shingles vaccine HZ/su met its ... TheStreet.com, 5 hours ago
[x]  

346 images for glaxo

Financial Director, 1 day ago
Reuters India, 8 hours ago
Yahoo! UK and Ireland, 1 day ago
Bidness Etc, 3 days ago
American Banking News, 6 days ago
DirectorsTalk, 10 hours ago
Pharmaceutical Business Review, 1 day ago
North Jersey.com, 1 week ago
Capital Bay, 1 week ago
West Australian, 12 hours ago
West Australian

GlaxoSmithKline Shareholders Pass Deal With Novartis By Overwhelming Majority

GlaxoSmithKline Plc. (GSK: Quote,GSK.L) Thursday said at its General Meeting held earlier today, the sole resolution relating to the proposed major transaction with Swiss drugmaker Novartis AG (NVS: Quote) was passed by shareholders by an ...
 RTTNews.com13 hours ago GlaxoSmithKline CEO: Chin up, investors. Dividend's safe, and Novartis deal awaits  FiercePharma8 hours ago GlaxoSmithKline shareholders back Novartis transaction  FirstWord Pharma11 hours ago GSK shareholders approve asset swap deal with Novartis  4 Traders13 hours ago
[x]  

Agenus up on successful outcome of Glaxo Phase 3 shingles vaccine study

News Editor Thinly-traded nano cap Agenus (AGEN +11.3%) jumps on triple normal volume in response to the successful outcome of the Phase 3 clinical trial of GlaxoSmithKline's (GSK +2.4%) shingles vaccine candidate, HZ/su. One of the key components ...
 Seeking Alpha9 hours ago Agenus: GSK's ZOE-50 Phase 3 Study Meets Primary Endpoint - Quick Facts  RTTNews.com14 hours ago GSK Reports Positive Outcome of Phase III Study of Shingles Vaccine Containing Agenus Adjuvant  PharmaceuticalProcessing9 hours ago Positive Outcome of Phase 3 Study of GSK Shingles Vaccine Containing Agenus Adjuvant  EMoneyDaily14 hours ago
[x]  

Result of General Meeting

Regulatory Story GlaxoSmithKline PLC - GSK Released 12:48 18-Dec-2014 RNS Number : 1952A GlaxoSmithKline PLC 18 December 2014  Issued: Thursday 18 December 2014, London UK - LSE Announcement Result of General Meeting relating to the proposed ...
 London Stock Exchange7 hours ago GlaxoSmithKline PLC Result of General Meeting  ADVFN UK13 hours ago Potential GlaxoSmithKline PLC (GSK) Trade Has 3.75% Downside Protection  Individual.com2 days ago
Pharmafocus

Euro consortium to support Ebola vaccine development

GlaxoSmithKline (GSK) has announced the formation of a new European consortium that will support the firm's development of a new Ebola vaccine. GSK will partner up with researchers from the University of Oxford, Centre Hospitalier Universitaire ...
 Pharma Field13 hours ago GSK forms new European consortium to advance Ebola vaccine candidate  Pharmaceutical Technology14 hours ago GSK Ebola vaccine gets EU support  Pharmafocus1 day ago New European consortium to help advance development of GSK/NIH Ebola vaccine candidate  Pharmaceutical Business Review1 day ago

Glaxo CEO Says Dividend Is Secure After Analysts Question Payout

(Bloomberg) -- GlaxoSmithKline Plc's dividend is secure, Chief Executive Officer Andrew Witty said after analysts questioned whether the company could maintain its payout. Glaxo expects to maintain a dividend of 80 pence a share in 2014, the same ...
 Washington Post12 hours ago Glaxo's CEO Says Dividend Secure as Analysts Question Payout  Washington Post7 hours ago Glaxo Says Dividend Is Secure as Analysts Question Payout  Bloomberg11 hours ago
Yahoo! UK and Ireland

Will GlaxoSmithKline plc And AstraZeneca plc Make You Rich In 2015?

After falling 14% in 2014, GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) certainly won't have made you rich this year. AstraZeneca (LSE: AZN) (NYSE: AZN.US) has put on a spectacular show, by contrast, rising 26% this year. Glaxo loses, Astra wins. But ...
 Yahoo! UK and Ireland18 hours ago
Business Standard

GlaxoSmithKline Staffers Nervous As Job Cuts Loom

GLAXO has refused to rule out cutbacks at its Port Fairy pharmaceuticals factory as part of a massive global restructure. The British multinational announced extensive cutbacks to its American operations in recent weeks with its Australian ...
 BioSpace10 hours ago Malawi important to GlaxoSmithKline Pharmaceutical work  Nyasa Times1 day ago Select pharma shares rally on heavy volumes  Business Standard2 weeks ago Board of GlaxoSmithKline Pharma decides to change financial year  Business Standard1 month ago
[x]  
Reuters

New GSK shingles vaccine may challenge Merck after strong test data

LONDON (Reuters) - An experimental shingles vaccine from GlaxoSmithKline has produced impressive results in a late-stage study, giving the group's expanding vaccine unit a potential $1 billion boost. The data suggests the British company's new shot could be a ...
 Reuters13 hours ago New GlaxoSmithKline shingles vaccine may challenge Merck & Co after strong test data  Economic Times8 hours ago UPDATE 1-New GSK shingles vaccine may challenge Merck after strong test data  Reuters9 hours ago
[x]  
DirectorsTalk

GlaxoSmithKline scores a PhIII success for marathon shingles vaccine study

GlaxoSmithKline ($GSK) got some good news for its big vaccines group, scoring a pivotal Phase III win for its shingles vaccine HZ/su more than four years after the study was launched. The herpes zoster jab reduced the risk of shingles by 97.2% in ...
 FierceBiotech10 hours ago GlaxoSmithKline shingles vaccine hits goal in major study  Sharenet13 hours ago GlaxoSmithKline (GSK)'s Experimental Shingles Vaccine Hits Goal In Late-Stage Study 12/18/2014  ClinicSpace11 hours ago GlaxoSmithKline's Experimental Shingles Vaccine Hits Goal In Late-Stage Study  BioSpace12 hours ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less